Andexxa Conditional Approval in Europe

Andexxa Conditional Approval in Europe
Mar 6, 2019 7:54am

The Heart.Org reports that the the Rivaroxaban and Apixaban reversal agent Andexxa (andexanet alpha) has earned conditional approval by the European Medicines Agency. Click or tap here for details.

0 Comments

The Heart.Org reports that the the Rivaroxaban and Apixaban reversal agent Andexxa (andexanet alpha) has earned conditional approval by the European Medicines Agency. Click or tap here for details.

Leave A Comment

You must be logged in to Comment - Sign In